| Sr. No. |
Particulars |
Quarter ended 30.09.2007 (Unaudited) |
Quarter ended 30.09.2006 (Unaudited) |
Half Year ended 30.09.2007 (Unaudited) |
Half Year ended 30.09.2006 (Unaudited) |
Year ended 31.03.2007 (Audited) |
| 1 |
Income from Operations |
3398.90 |
3419.98 |
6285.29 |
6562.13 |
12840.07 |
| 2 |
Other income |
1.59 |
2.57 |
3.41 |
2.57 |
22.96 |
|
Total |
3400.49 |
3422.55 |
6288.70 |
6564.70 |
12863.03 |
| 3 |
Total Expenditure |
3296.41 |
3011.10 |
6416.69 |
5784.17 |
12249.18 |
|
a) (Increase) / Decrease in stock-in-trade |
216.50 |
(33.23) |
252.13 |
(118.29) |
(85.28) |
|
b) Consumption of Raw materials |
2004.66 |
2229.88 |
3875.79 |
4300.12 |
8364.74 |
|
c) Staff Cost |
404.66 |
338.23 |
790.42 |
683.46 |
1519.87 |
|
d) Other Expenditure |
670.59 |
476.22 |
1498.35 |
918.88 |
2449.85 |
|
Operating Profit/ (Loss) |
104.08 |
411.45 |
(127.99) |
780.53 |
613.85 |
| 4 |
Interest |
48.18 |
67.00 |
88.08 |
72.71 |
528.31 |
| 5 |
Depreciation and Amortisation |
1229.48 |
1229.46 |
2458.96 |
2458.92 |
4905.80 |
| 6 |
Profit / (Loss) before Extraordinary Items |
(1173.58) |
(885.01) |
(2675.03) |
(1751.10) |
(4820.26) |
| 7 |
Extraordinary Items |
- |
- |
- |
- |
(8474.80) |
| 8 |
Profit / (Loss) after Extraordinary Items |
(1173.58) |
(885.01) |
(2675.03) |
(1751.10) |
(13295.06) |
| 9 |
Provision for FBT |
4.47 |
0.13 |
7.72 |
2.02 |
22.55 |
| 10 |
Deferred Tax Reversal |
- |
- |
- |
- |
(2,444.49) |
| 11 |
Net Profit /(Loss) |
(1178.05) |
(885.14) |
(2682.75) |
(1753.12) |
(15762.10) |
| 12 |
Paid-up equity share capital |
4371.15 |
4220.80 |
4371.15 |
4220.80 |
4220.80 |
| 13 |
Reserves excluding revaluation reserves |
|
|
|
|
43907.72 |
| 14 |
Earning Per Share (in Rs.) - |
|
|
|
|
|
|
Basic & Diluted |
(0.54) |
(0.42) |
(1.24) |
(0.83) |
(7.50) |
| 15 |
Aggregate of Non-Promoter Shareholding |
|
|
|
|
|
|
Number of Shares |
148225952 |
140708412 |
148225952 |
140708412 |
140708412 |
|
Percentage of shareholding |
67.82% |
66.67% |
67.82% |
66.67% |
66.67% |
|
|
|
|
|
|
|
Notes:
- The above results were reviewed by the audit committee and subsequently have been taken on record by the Board of Directors in its meeting held on 18th October, 2007 and limited review of the same has been carried out by the statutory auditors.
- The Company is exclusively engaged in the Pharmaceutical Business segment. Capital employed as on 30th September, 2007 is Rs. 72959.24 Lacs.
- Other expenditure includes a charge of Rs. 112.88 Lacs on account of foreign exchange fluctuations . Further an additional sum of Rs. 335.61 Lacs, for Quarter ending June'07, towards foreign exchange fluctuation, has also been been considered in six monthly results.
- Pending settlement, interest of Rs. 549.73 has not been provided on fixed deposits, non- CDR Banks/FI's having exposure of Rs. 2202.91 Lacs and CDR banks on account of interest payment on OTS. Scheme of arrangement & compromise under Section 391 of Companies Act, 1956 is pending adjudication before Hon'ble Himachal Pradesh High Court at Shimla.
- During the Quarter, NIL shareholders' complaint were received.
- Consolidated Sales & profit after tax of the company for quarter ending September 30,2007 stands at Rs. 4129.87 Lacs & Rs.1297.61 Lacs respectively whereas EPS for the quarter & six months ended September'07 stands at Rs.(-) 0.59 & Rs. (-) Rs. 1.31 respectively.
- .The comparative figures are regrouped and reclassified, wherever considered necessary.
|
|
|
|
|
|
|
|
Place: New Delhi
Date: 18.10.2007 |
(Sushil Suri)
Chairman & Managing Director |
